Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiamen Helengte Biotechnology is a life sciences company based in China that specializes in the research, development, and production of core raw materials for molecular diagnostics. The company provides a comprehensive suite of high-performance enzymes, including Taq DNA polymerases, reverse transcriptases, and isothermal amplification enzymes, tailored for PCR, qPCR, and NGS applications. In addition to enzymes, Helengte develops recombinant antigens and monoclonal antibodies used in various in vitro diagnostic (IVD) platforms. By leveraging its protein engineering and large-scale fermentation capabilities, the company supports global diagnostic manufacturers and research institutions with stable and sensitive biological reagents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiamen Helengte Biotechnology.